Company News » Events » The CRISRP Medicine Conference

The CRISPR Medicine Conference

Name: The CRISRP Medicine Conference
Start: 2024-04-23 00:00:00
End: 2024-04-25 00:00:00
Location: The CRISRP Medicine Conference

23-25 April 2024
Øksnehallen, Copenhagen, Denmark

GenScript is excited to announce our presence at the first CRISPR Medicine Conference, taking place at Øksnehallen, Copenhagen, Denmark, from April 23rd to 25th, 2024.

Celebrate this fascinating new conference with us that brings together leaders, experts and researchers of the European CRISPR research field and gain deeper insights into the most important topics in the therapeutic gene-editing field: Tools, Delivery, Safety, Functional Genomics, Standards and Regulations, Pre-clinical Research and Clinical Trials.

We are looking forward to meeting you at CRISPR MED and share insights into our top-notch products and services and on how our offerings can contribute to your success. Our team of experts will be available to answer your questions and discuss the latest developments in CRISPR technologies with you. We can support you needs from research to GMP stage!

Come visit us at booth B-4-S and let's explore the future of CRISPR together!

Our Experts at CRISPR MED 2024

Cristobal Almendros
Team Leader Sales and Technical Support

Olivier Binggeli
Sales Leader

Christoph Lippuner
Sales Account Manager

Fan Zhou
Senior Scientist Molecular Biology

Highlights

With us at CRISPR Med is our R&D Scientist Dr. Fan Zhou who will share our latest advancements and technologies with you.

Join us on Thursday, April 25th at 9:50 – 10:05 at the Main Stage for an engaging presentation by Dr. Fan Zhou, Senior Scientist Molecular Biology at GenScript Biotech, as he shares insights into "Novel DNA Payloads and One-Stop CRISPR Toolbox Accelerate Non-Viral Gene Editing Therapeutics Development" featuring our latest tools and services that were developed having you and your success in mind. GenScript is committed to the development of non-viral DNA payloads and providing synthesis services of various DNA formats with reduced cytotoxicity and off-target probability and improved efficiency.

Check the Agenda